echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Natural Products News > Tu Youyou team: Breakthrough in artemisinin resistance and new progress in the treatment of lupus erythematosus indications

    Tu Youyou team: Breakthrough in artemisinin resistance and new progress in the treatment of lupus erythematosus indications

    • Last Update: 2019-06-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On the evening of June 16, Xinhua put out a big suspense: according to Xinhua, Tu youyou's team will announce a major scientific breakthrough the next day Xinhua news agency client released the news with a video and a poem In the video, Tu Youyou, Nobel Laureate in physiology or medicine, said that once the malaria parasite becomes resistant to artemisinin combination therapy, there will be no cure for malaria, and human beings are bound to suffer a catastrophe In addition, Wang Jigang, a researcher at the artemisinin research center of the Chinese Academy of traditional Chinese medicine, said that without artemisinin, millions of people would die every year According to Xinhua News Agency on June 17th, in response to the "drug resistance" problem of artemisinin in some parts of the world in recent years, Tu youyou and her team have made new breakthroughs in "Research on malaria resistance mechanism", "cause of drug resistance", "adjustment of treatment means" and other aspects after years of hard work, and put forward practical treatment plans to deal with the "artemisinin resistance" problem in the near future New progress has been made in the treatment of indications such as lupus erythematosus and in the research of traditional Chinese medicine, which has been highly recognized by the World Health Organization and authoritative experts at home and abroad Under the influence of this news, artemisinin plate opened up sharply, kunyao group opened up one word trading limit, with more than 2 million sealed orders, Yuheng pharmaceutical industry trading limit, Cr Shuanghe, XinHeCheng and Zhejiang Pharmaceutical Group opening high It is reported that after more than three years of scientific research, Tu youyou's team has made new breakthroughs in "malaria resistance mechanism research", "drug resistance causes", "adjustment of treatment methods", etc., and put forward new treatment solutions: first, appropriately extend the medication time, from three days to five or seven days; second, replace the adjuvant drugs that have produced drug resistance in artemisinin combination therapy, with stable effect See the shadow from the pole According to the approval for clinical trials of drugs issued by the State Drug Administration, the application of "clinical trials for indications of dihydroartemisinin tablets in the treatment of systemic lupus erythematosus and discoid systemic lupus erythematosus" submitted by the Institute of traditional Chinese medicine of the Chinese Academy of Chinese medicine where Tu youyou's team is located has been approved Kunming Pharmaceutical Group Co., Ltd as the responsible unit to carry out clinical trials According to the Chinese Academy of traditional Chinese medicine, artemisinin and other traditional Chinese medicine research theories written by Tu Youyou, researcher of the Chinese Academy of traditional Chinese medicine, Liao Fulong and other experts are expected to be included in the international authoritative medical textbook Oxford medical textbook (6th Edition), which is to be reprinted for the first time The industry believes that this will become an important practical achievement of "going out" of TCM culture  
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.